Apotex Health Corp.
Apotex Health Corp.
- Market cap
- $9.41B
- P/E ratio
- 25.47
Your view on APTX.TO
Overview
What the company does, where it operates, and who runs it.
About Apotex Health Corp.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Jeff Watson
- Headquarters
- 150 Signet Drive, Toronto, ON, CA
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Jeff Watson
- Headquarters
- 150 Signet Drive, Toronto, ON, CA
Apotex Health Corp. operates as a pharmaceutical manufacturing company in Canada, the United States, Mexico, and India.
The company develops, manufactures, and distributes a broad portfolio of prescription and generic pharmaceuticals, oncology biosimilar pharmaceuticals, branded specialty pharmaceuticals, and branded consumer health and wellness products.
It operates through three business lines including conventional generic pharmaceuticals; specialty generic pharmaceuticals; and brands & biosimilars.
The company has a a strategic partnership with Halo Pharmaceutical, Inc. The company was formerly known as Artemis Parent, Inc. and changed its name to Apotex Health Corp. in May 2026. Apotex Health Corp. was founded in 1974 and is headquartered in Toronto, Canada. Apotex Health Corp. operates as a subsidiary of SK Artemis Holdings, II, LLC
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Apotex Health Corp.. Starting points for Apotex Health Corp.: P/E 25.5, EPS C$1.61, beta -0.71 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Apotex Health Corp.. Apotex Health Corp. paid C$0.06 per share over the last year — a 0.1% yield at the current C$41.17 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Apotex Health Corp.. Trailing twelve-month EPS for Apotex Health Corp. stands at C$1.61. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This yearYear to Mar 2027 | Next yearYear to Mar 2028 |
|---|---|---|
| Average estimate | CAD 1.96 | CAD 2.38 |
| Lowest estimate | CAD 1.87 | CAD 2.20 |
| Highest estimate | CAD 2.07 | CAD 2.63 |
| Number of analysts | 7 | 7 |
| A year ago | CAD 1.61 | — |
| Growth vs a year ago | +21.5% | — |
Revenue estimates
| Total | This yearYear to Mar 2027 | Next yearYear to Mar 2028 |
|---|---|---|
| Average estimate | CAD 3.44B | CAD 3.72B |
| Lowest estimate | CAD 3.39B | CAD 3.60B |
| Highest estimate | CAD 3.45B | CAD 3.77B |
| Number of analysts | 14 | 14 |
| A year ago | CAD 3.49B | — |
| Growth vs a year ago | −1.5% | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Apotex Health Corp.. Apotex Health Corp. has reported as a listed company since 2026. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | Mkt cap |
|---|---|---|---|---|---|
| GUD.TOKnight Therapeutics Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | $1.1B | ||
| LLY.TOEli Lilly and Company | Healthcare | Drug Manufacturers - General | $1.7T | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| LMLLFPharmadrug Inc. | Healthcare | OTC | $746,817 | ||
| LNTHLantheus Holdings, Inc. | Healthcare | NASDAQ | $6.7B | ||
| LOVE.TOCannara Biotech Inc. | Healthcare | TSX | $198.1M | ||
| LOVFFCannara Biotech Inc. | Healthcare | OTC | $125.5M | ||
| LOWLFLowell Farms Inc. | Healthcare | OTC | $1,815 | ||
| LTHOLegacy Technology Holdings, Inc. | Healthcare | OTC | $1,720 | ||
| LUFFFHerbal Dispatch Inc. | Healthcare | OTC | $17.1M | ||
| LVRLFCordovaCann Corp. | Healthcare | OTC | $3.3M | ||
| LVVVLiveWire Ergogenics, Inc. | Healthcare | OTC | $1.6M | ||
| LVZPFLivzon Pharmaceutical Group Inc. | Healthcare | OTC | $6.1B | ||
| LYPHFLuye Pharma Group Ltd. | Healthcare | OTC | $1.5B | ||
| MAJIMarijuana Inc. | Healthcare | OTC | $1.8M | ||
| Ticker | Fund | Fund assets | % of the fund |
|---|---|---|---|
| TGED.TOTD Active Global Enhanced Dividend ETF | $1.6B in assets | 1.83% | |
| FBCGFidelity Blue Chip Growth ETF | $7.3B in assets | 0.08% | |
| TTP.TOTD Canadian Equity Index ETF | $6.8B in assets | 0.08% | |
| QCN.TOMackenzie Canadian Equity Index ETF | $6.4B in assets | 0.08% | |
| MCSM.TOManulife Multifactor Canadian SMID Cap Index ETF | $334M in assets | 0.62% | |
| DANC.TODesjardins Market Neutral ETF | $201M in assets | 0.62% | |
| ISCFiShares International Small-Cap Equity Factor ETF | $717M in assets | 0.06% | |
Largest holders first, then the funds most concentrated in APTX.TO.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Apotex Health Corp.